価格表

在庫・価格 : 2024年05月18日 08時38分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
TIMP-1, Human, ELISA Kit, Quantikine (96 well)
データシート※最新のデータシートでない場合があります
DTM100 RSDアールアンドディー システムス
R&D Systems, Inc.
1 kit ¥116,000 1個 追加

在庫・価格 : 2024年05月18日 08時38分 現在

TIMP-1, Human, ELISA Kit, Quantikine (96 well)

  • 商品コード:DTM100
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥116,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Waubant E et al. Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology 1999 Oct;53(7):1397-401
Waubant E et al
1999/01/01
human serum PubMed
2 Waubant E et al. IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis. J. Interferon Cytokine Res. 2001 Mar;21(3):181-5
Waubant E et al
2001/01/01
human serum PubMed
3 Oelmann E et al. Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells. Blood 2002 Jan;99(1):258-67
Oelmann E et al
2002/01/01
human plasma and H/R-S cell culture supernate PubMed
4 Szamatowicz J et al. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis. Hum. Reprod. 2002 Feb;17(2):284-8
Szamatowicz J et al
2002/01/01
Sample Type: Peritoneal Fluid PubMed
5 Dam奪s JK et al. Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation 2002 Jul;106(1):36-42
Dam奪s JK et al
2002/01/01
Sample Type: Cell Supernates,Plasma (EDTA) PubMed
6 Alby C et al. Preanalytical aspects regarding the measurement of metalloproteinase-9 and tissue inhibitor or metalloproteinase-1 in blood. Clin. Chim. Acta 2002 Nov;325(1-2):183-6
Alby C et al
2002/01/01
Sample Type: Serum PubMed
7 Fireman E et al. Induced sputum-retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases. Clin. Exp. Immunol. 2002 Nov;130(2):331-7
Fireman E et al
2002/01/01
Sample Type: Saliva PubMed
8 Cataldo DD et al. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest 2002 Nov;122(5):1553-9
Cataldo DD et al
2002/01/01
Sample Type: Sputum PubMed
9 D"Agostino P et al. Matrix metalloproteinases production in malignant pleural effusions after talc pleurodesis. Clin. Exp. Immunol. 2003 Oct;134(1):138-42
D"Agostino P et al
2003/01/01
Sample Type: Pleural Effusion,Serum PubMed
10 Ulrich D et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren"s disease. Plast. Reconstr. Surg. 2003 Oct;112(5):1279-86
Ulrich D et al
2003/01/01
Species: Human, Application: Serum PubMed
11 Tziakas DN et al. Anti-inflammatory cytokine profile in acute coronary syndromes: behavior of interleukin-10 in association with serum metalloproteinases and proinflammatory cytokines. Int. J. Cardiol. 2003 Dec;92(2-3):169-75
Tziakas DN et al
2003/01/01
Sample Type: Serum PubMed
12 Kang MJ et al. Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow. J. Korean Med. Sci. 2003 Dec;18(6):821-7
Kang MJ et al
2003/01/01
Sample Type: Homogenized Tissue - Protocol Included PubMed
13 Rhee JS et al. TIMP-1 alters susceptibility to carcinogenesis. Cancer Res. 2004 Feb;64(3):952-61
Rhee JS et al
2004/01/01
Sample Type: Homogenized Tissue - Protocol Included,Serum PubMed
14 Jumper C et al. Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment. Respir Med
Jumper C et al
2004/01/01
Sample Type: Serum PubMed
15 Kuyvenhoven JP et al. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury. Thromb. Haemost. 2004 Mar;91(3):506-13
Kuyvenhoven JP et al
2004/01/01
Sample Type: Plasma (Citrate) PubMed
16 Nakano Y et al. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J. Am. Coll. Cardiol. 2004 Mar;43(5):818-25
Nakano Y et al
2004/01/01
Sample Type: Homogenized Tissue PubMed
17 Lateef H et al. All-trans-retinoic acid suppresses matrix metalloproteinase activity and increases collagen synthesis in diabetic human skin in organ culture. Am. J. Pathol. 2004 Jul;165(1):167-74
Lateef H et al
2004/01/01
Sample Type: Cell Supernates PubMed
18 Pantsulaia I et al. Heritability of circulating growth factors involved in the angiogenesis in healthy human population. Cytokine 2004 Sep;27(6):152-8
Pantsulaia I et al
2004/01/01
Sample Type: Plasma (Not Specified) PubMed
19 Migita K et al. Suppressive effect of leflunomide metabolite (A77 1726) on metalloproteinase production in IL-1beta stimulated rheumatoid synovial fibroblasts. Clin. Exp. Immunol. 2004 Sep;137(3):612-6
Migita K et al
2004/01/01
Sample Type: Cell Supernates PubMed
20 Domeij H et al. Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 production in human gingival fibroblasts: the role of protein kinase C. J. Periodont. Res. 2004 Oct;39(5):308-14
Domeij H et al
2004/01/01
Sample Type: Cell Supernates PubMed
21 Chellat F et al. Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles. Biomaterials 2005 Mar;26(9):961-70
Chellat F et al
2005/01/01
Species: Human, Sample type: Cell Supernates PubMed
22 Maldonado A et al. Pre-exposure to high glucose augments lipopolysaccharide-stimulated matrix metalloproteinase-1 expression by human U937 histiocytes. J. Periodont. Res. 2004 Dec;39(6):415-23
Maldonado A et al
2004/01/01
Sample Type: Cell Supernates PubMed
23 Claveau I et al. Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans. Matrix Biol. 2004 Nov;23(7):477-86
Claveau I et al
2004/01/01
Sample Type: Cell Supernates PubMed
24 Behera AK et al. Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine lyme arthritis. Infect. Immun. 2005 Jan;73(1):126-34
Behera AK et al
2005/01/01
Sample Type: Cell Supernates,Synovial Fluid PubMed
25 Sagel SD et al. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis. Pediatr. Pulmonol. 2005 Mar;39(3):224-32
Sagel SD et al
2005/01/01
human sputum PubMed
26 LeMaire SA et al. Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves. J. Surg. Res. 2005 Jan;123(1):40-8
LeMaire SA et al
2005/01/01
Species: Human, Sample type: Homogenized Tissue PubMed
27 Studer RK et al. p38 MAPK and COX2 inhibition modulate human chondrocyte response to TGF-beta. J. Orthop. Res. 2005 Mar;23(2):454-61
Studer RK et al
2005/01/01
Sample Type: Cell Supernates PubMed
28 Rouy D et al. Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation. Anal. Biochem. 2005 Mar;338(2):294-8
Rouy D et al
2005/01/01
Sample Type: Plasma (Citrate) PubMed
29 Finkelstein A et al. Temporal association between circulating proteolytic, inflammatory and neurohormonal markers in patients with coronary ectasia. Atherosclerosis 2005 Apr;179(2):353-9
Finkelstein A et al
2005/01/01
Sample Type: Serum PubMed
30 Tayebjee MH et al. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension. Am. J. Hypertens. 2005 Mar;18(3):325-9
Tayebjee MH et al
2005/01/01
Sample Type: Plasma (Not Specified) PubMed
31 Manginas A et al. Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: correlations with serum troponin I. Clin Cardiol 2005 Apr;28(4):182-6
Manginas A et al
2005/01/01
Sample Type: Plasma (Not Specified) PubMed
32 Simpson JL et al. Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am. J. Respir. Crit. Care Med. 2005 Sep;172(5):559-65
Simpson JL et al
2005/01/01
Sample Type: Sputum PubMed
33 Ko FW et al. A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion. Chest 2005 Jun;127(6):1919-27
Ko FW et al
2005/01/01
Sample Type: BALF,Serum PubMed
34 Domeij H et al. Cell expression of MMP-1 and TIMP-1 in co-cultures of human gingival fibroblasts and monocytes: the involvement of ICAM-1. Biochem. Biophys. Res. Commun. 2005 Dec;338(4):1825-33
Domeij H et al
2005/01/01
Species: Human, Sample type: Cell Supernates PubMed
35 Li W et al. Basement membrane dissolution and reassembly by limbal corneal epithelial cells expanded on amniotic membrane. Invest. Ophthalmol. Vis. Sci. 2006 Jun;47(6):2381-9
Li W et al
2006/01/01
Species: Human, Sample type: Cell Supernates PubMed
36 Holven KB et al. Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects. Stroke 2006 Jul;37(7):1731-6
Holven KB et al
2006/01/01
Species: Human, Sample type: Serum PubMed
37 Demeulemeester D et al. Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in mice does not affect adipogenesis or adipose tissue development. Thromb. Haemost. 2006 Jun;95(6):1019-24
Demeulemeester D et al
2006/01/01
Species: Human, Sample type: Plasma (Not Specified) PubMed
38 Fluhr H et al. Human chorionic gonadotropin inhibits insulin-like growth factor-binding protein-1 and prolactin in decidualized human endometrial stromal cells. Fertil. Steril. 2006 Jul;86(1):236-8
Fluhr H et al
2006/01/01
Sample Type: Cell Supernates PubMed
39 Fearon U et al. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Arthritis Rheum. 2006 Oct;54(10):3152-62
Fearon U et al
2006/01/01
Species: Human, Application: Cell Supernates PubMed
40 Ho FM et al. Opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells. J. Cell. Biochem. 2007 May;101(2):442-50
Ho FM et al
2007/01/01
Species: Human, Sample type: Cell Supernates PubMed
41 Aznaouridis K et al. Divergent associations of tissue inhibitors of metalloproteinases-1 and -2 with the prothrombotic/fibrinolytic state. Atherosclerosis 2007 Nov;195(1):212-5
Aznaouridis K et al
2007/01/01
Species: Human, Sample type: Plasma PubMed
42 Andrian E et al. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model. J. Cell. Physiol. 2007 Apr;211(1):56-62
Andrian E et al
2007/01/01
Sample Type: Cell Supernates PubMed
43 Bodet C et al. Actinobacillus actinomycetemcomitans lipopolysaccharide regulates matrix metalloproteinase, tissue inhibitors of matrix metalloproteinase, and plasminogen activator production by human gingival fibroblasts: a potential role in connective ti
Bodet C et al
2007/01/01
Species: Human, Sample type: Cell Supernates PubMed
44 Zhao Z et al. Borrelia burgdorferi-induced monocyte chemoattractant protein-1 production in vivo and in vitro. Biochem. Biophys. Res. Commun. 2007 Jun;358(2):528-33
Zhao Z et al
2007/01/01
Species: Human, Sample type: Homogenized Tissue, Serum PubMed
45 Thrailkill KM et al. Matrix metalloproteinase-2 dysregulation in type 1 diabetes. Diabetes Care 2007 Sep;30(9):2321-6
Thrailkill KM et al
2007/01/01
Species: Human, Sample type: Plasma (Not Specified) PubMed
46 Jones JA et al. Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials. J Biomed Mater Res A 2008 Jan;84(1):158-66
Jones JA et al
2008/01/01
Species: Human, Sample type: Cell Supernates PubMed
47 Kellouche S et al. Tissue engineering for full-thickness burns: a dermal substitute from bench to bedside. Biochem. Biophys. Res. Commun. 2007 Nov;363(3):472-8
Kellouche S et al
2007/01/01
Species: Human, Sample type: Cell Supernates PubMed
48 Goleva E et al. Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. J. Allergy Clin. Immunol. 2007 Nov;120(5):1065-72
Goleva E et al
2007/01/01
Species: Human, Sample type: BALF PubMed
49 Tuomainen AM et al. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler. Thromb. Vasc. Biol. 2007 Dec;27(12):2722-8
Tuomainen AM et al
2007/01/01
Species: Human, Sample type: Serum PubMed
50 Li J et al. Suppressive effects of leflunomide on leptin-induced TIMP-1 production involves on hepatic stellate cell proliferation and apoptosis. Eur. J. Pharmacol. 2008 Feb;580(1-2):63-9
Li J et al
2008/01/01
Species: Human, Application: Cell Supernates PubMed
51 Huh JW et al. Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis? Chest 2008 May;133(5):1101-6
Huh JW et al
2008/01/01
Species: Human, Application: BALF PubMed
52 Kosmala W et al. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function. Int J Obes (Lond) 2008 May;32(5):763-71
Kosmala W et al
2008/01/01
Species: Human, Application: Plasma (Not Specified) PubMed
53 Chang DT et al. Lymphocyte/macrophage interactions: biomaterial surface-dependent cytokine, chemokine, and matrix protein production. J Biomed Mater Res A 2008 Dec;87(3):676-87
Chang DT et al
2008/01/01
Sample Type: Cell Supernates PubMed
54 Nicol GR et al. Use of an immunoaffinity-mass spectrometry-based approach for the quantification of protein biomarkers from serum samples of lung cancer patients. Mol. Cell Proteomics 2008 Oct;7(10):1974-82
Nicol GR et al
2008/01/01
Sample Type: Serum PubMed
55 Glader P et al. Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space. Eur. Respir. J. 2008 Sep;32(3):644-50
Glader P et al
2008/01/01
Sample Type: BALF PubMed
56 Bendrik C et al. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo. Cancer Res. 2008 May;68(9):3405-12
Bendrik C et al
2008/01/01
Species: Human, Application: Homogenized Tissue PubMed
57 Zdzisiナгka B et al. Matrix metalloproteinases-1 and -2, and tissue inhibitor of metalloproteinase-2 production is abnormal in bone marrow stromal cells of multiple myeloma patients. Leuk. Res. 2008 Nov;32(11):1763-9
Zdzisiナгka B et al
2008/01/01
Species: Human, Application: Cell Supernates PubMed
58 Huh JE et al. Protective effects of butanol fraction from Betula Platyphyla var. japonica on cartilage alterations in a rabbit collagenase-induced osteoarthritis. J Ethnopharmacol 2009 Jun;123(3):515-21
Huh JE et al
2009/01/01
Sample Type: Synovial Fluid PubMed
59 McKeown S et al. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur. Respir. J. 2009 Jan;33(1):77-84
McKeown S et al
2009/01/01
Sample Type: BALF PubMed
60 Castellano G et al. Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression. Clin. Cancer Res. 2008 Nov;14(22):7470-80
Castellano G et al
2008/01/01
Sample Type: Plasma (Heparin) PubMed
61 Kapsoritakis AN et al. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease. BMC Gastroenterol 2008;8:55
Kapsoritakis AN et al
2008/01/01
Sample Type: Serum PubMed
62 Wang Z et al. Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis? Eur. Respir. J. 2009 Jul;34(1):145-55
Wang Z et al
2009/01/01
Sample Type: Cell Supernates PubMed
63 Glass-Marmor L et al. Immunomodulation by chronobiologically-based glucocorticoids treatment for multiple sclerosis relapses. J. Neuroimmunol. 2009 May;210(1-2):124-7
Glass-Marmor L et al
2009/01/01
Sample Type: Serum PubMed
64 Gogly B et al. Gingival fibroblast inhibits MMP-7: evaluation in an ex vivo aorta model. J. Mol. Cell. Cardiol. 2009 Aug;47(2):296-303
Gogly B et al
2009/01/01
Sample Type: Cell Supernates PubMed
65 Furuzawa-Carballeda J et al. Effect of polymerized-type I collagen in knee osteoarthritis. I. In vitro study. Eur. J. Clin. Invest. 2009 Jul;39(7):591-7
Furuzawa-Carballeda J et al
2009/01/01
Sample Type: Cell Supernates PubMed
66 O"Kane CM et al. Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit. Care Med. 2009 Jul;37(7):2242-9
O"Kane CM et al
2009/01/01
Sample Type: BALF PubMed
67 Roderfeld M et al. Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation. J. Cyst. Fibros. 2009 Sep;8(5):338-47
Roderfeld M et al
2009/01/01
Sample Type: Serum PubMed
68 Lorente L et al. Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis. Crit Care 2009;13(5):R158
Lorente L et al
2009/01/01
Sample Type: Serum PubMed
69 Reikvam H et al. Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation. Eur. J. Haematol. 2010 Mar;84(3):239-51
Reikvam H et al
2010/01/01
Sample Type: Cell Supernates PubMed
70 Pitteri SJ et al. Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. PLoS ONE 2009;4(11):e7916
Pitteri SJ et al
2009/01/01
Sample Type: Plasma (Not Specified) PubMed
71 Teles RM et al. High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions. Infect. Immun. 2010 Mar;78(3):1012-21
Teles RM et al
2010/01/01
Sample Type: Cell Supernates,Serum PubMed
72 Guo J et al. A DDX5 S480A polymorphism is associated with increased transcription of fibrogenic genes in hepatic stellate cells. J. Biol. Chem. 2010 Feb;285(8):5428-37
Guo J et al
2010/01/01
Sample Type: Cell Supernates PubMed
73 Tolosana JM et al. Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapy. Eur. J. Heart Fail. 2010 May;12(5):492-8
Tolosana JM et al
2010/01/01
Sample Type: Plasma (Not Specified) PubMed
74 Green JA et al. Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-kappaB- and Activator Protein-1-dependent monocyte networks. J. Immunol. 2010 Jun;184(11):6492-503
Green JA et al
2010/01/01
Sample Type: Cell Supernates PubMed
75 Mroczko B et al. The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients. Int J Colorectal Dis 2010 Oct;25(10):1177-84
Mroczko B et al
2010/01/01
Sample Type: Serum PubMed
76 Katial RK et al. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases. J. Allergy Clin. Immunol. 2010 Oct;126(4):738-44
Katial RK et al
2010/01/01
Sample Type: Sputum PubMed
77 Idriss NK et al. Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor. Thromb. Haemost. 2010 Nov;104(5):1029-37
Idriss NK et al
2010/01/01
Sample Type: Plasma (Citrate) PubMed
78 Farlow EC et al. A multi-analyte serum test for the detection of non-small cell lung cancer. Br. J. Cancer 2010 Oct;103(8):1221-8
Farlow EC et al
2010/01/01
Sample Type: Serum PubMed
79 Hansson J et al. Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study. PLoS ONE 2011;6(1):e16185
Hansson J et al
2011/01/01
Sample Type: Serum PubMed
80 Symeonidis C et al. Interleukin-6 and the matrix metalloproteinase response in the vitreous during proliferative vitreoretinopathy. Cytokine 2011 May;54(2):212-7
Symeonidis C et al
2011/01/01
Sample Type: Vitreous Humor PubMed
81 Meissburger B et al. Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans. Diabetologia 2011 Jun;54(6):1468-79
Meissburger B et al
2011/01/01
Sample Type: Serum PubMed
82 Kluger HM et al. Plasma markers for identifying patients with metastatic melanoma. Clin. Cancer Res. 2011 Apr;17(8):2417-25
Kluger HM et al
2011/01/01
Sample Type: Plasma (EDTA) PubMed
83 J旦nsson S et al. Increased levels of leukocyte-derived MMP-9 in patients with stable angina pectoris. PLoS ONE 2011;6(4):e19340
J旦nsson S et al
2011/01/01
Sample Type: Cell Supernates,Plasma (Heparin),Serum PubMed
84 Geraghty P et al. TLR4 protein contributes to cigarette smoke-induced matrix metalloproteinase-1 (MMP-1) expression in chronic obstructive pulmonary disease. J. Biol. Chem. 2011 Aug;286(34):30211-8
Geraghty P et al
2011/01/01
Sample Type: Cell Supernates PubMed
85 Kong MY et al. Early elevation of matrix metalloproteinase-8 and -9 in pediatric ARDS is associated with an increased risk of prolonged mechanical ventilation. PLoS ONE 2011;6(8):e22596
Kong MY et al
2011/01/01
Sample Type: Tracheal Aspirates PubMed
86 Kong MY et al. Matrix metalloproteinase activity in pediatric acute lung injury. Int J Med Sci 2009;6(1):9-17
Kong MY et al
2009/01/01
Sample Type: Endotracheal aspirate PubMed
87 Pesta M et al. Prognostic significance of TIMP-1 in non-small cell lung cancer. Anticancer Res. 2011 Nov;31(11):4031-8
Pesta M et al
2011/01/01
Sample Type: Plasma (EDTA) PubMed
88 Jaedicke KM et al. Validation and quality control of ELISAs for the use with human saliva samples. J. Immunol. Methods 2012 Mar;377(1-2):62-5
Jaedicke KM et al
2012/01/01
Sample Type: Saliva PubMed
89 Symeonidis C et al. Interleukin-6 and matrix metalloproteinase expression in the subretinal fluid during proliferative vitreoretinopathy: correlation with extent, duration of RRD and PVR grade. Cytokine 2012 Jul;59(1):184-90
Symeonidis C et al
2012/01/01
Sample Type: Subretinal fluid PubMed
90 Ugarte-Gil CA et al. Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis. PLoS ONE 2013;8(4):e61333
Ugarte-Gil CA et al
2013/01/01
Sample Type: Sputum PubMed
91 Fontani F et al. Redox regulation of MMP-3/TIMP-1 ratio in intestinal myofibroblasts: effect of N-acetylcysteine and curcumin. Exp. Cell Res. 2014 Apr;323(1):77-86
Fontani F et al
2014/01/01
Sample Type: Cell culture supernatant PubMed
92 Lorente L et al. Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury. PLoS ONE 2014;9(4):e94370
Lorente L et al
2014/01/01
Sample Type: Serum PubMed
93 Uezumi A et al. Identification and characterization of PDGFRα+ mesenchymal progenitors in human skeletal muscle. Cell Death Dis 2014;5:e1186
Uezumi A et al
2014/01/01
Sample Type: Cell Culture Supernates PubMed
94 Zhao R et al. Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model. J Transl Med 2014;12(1):330
Zhao R et al
2014/01/01
Sample Type: Serum,Synovial Fluid PubMed
95 Kmiecik AM et al. Metallothionein-3 Increases Triple-Negative Breast Cancer Cell Invasiveness via Induction of Metalloproteinase Expression. PLoS ONE 2015;10(5):e0124865
Kmiecik AM et al
2015/01/01
Sample Type: Cell Culture Supernates PubMed
96 Nalluri S et al. TIMP-1 Inhibits Apoptosis in Lung Adenocarcinoma Cells via Interaction with Bcl-2. PLoS ONE 2015;10(9):e0137673
Nalluri S et al
2015/01/01
Sample Type: Cell Culture Supernates,Cell Lysates PubMed
97 Thevenard J et al. Low-density lipoprotein receptor-related protein-1 mediates endocytic clearance of tissue inhibitor of metalloproteinases-1 and promotes its cytokine-like activities. PLoS ONE 2014;9(7):e103839
Thevenard J et al
2014/01/01
Sample Type: Cell Culture Supernates PubMed
98 Yang J et al. Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nat Commun 2016 Dec;7:13710
Yang J et al
2016/01/01
Sample Type: Plasma PubMed
99 Mieczkowska J et al. Relationship between Serum Levels of Metalloproteinase-8 and Tissue Inhibitor of Metalloproteinases-1 and Exercise Test Results in Postmenopausal Women. Dis. Markers 2016;2016:7169531
Mieczkowska J et al
2016/01/01
Sample Type: Serum PubMed
100 Ni単o ME et al. TIMP1 and MMP9 are predictors of mortality in septic patients in the emergency department and intensive care unit unlike MMP9/TIMP1 ratio: Multivariate model. PLoS ONE 2017;12(2):e0171191
Ni単o ME et al
2017/01/01
Sample Type: Serum PubMed
101 Schmalz G et al. MMP-8 and TIMP-1 are associated to periodontal inflammation in patients with rheumatoid arthritis under methotrexate immunosuppression - First results of a cross-sectional study. J Microbiol Immunol Infect 2017 Sep;
Schmalz G et al
2017/01/01
Species: Human PubMed
102 Gusella M et al. Plasma matrix metalloprotease 9 correlates with blood lymphocytosis, leukemic cell invasiveness, and prognosis in B-cell chronic lymphocytic leukemia. Tumour Biol. 2017 Feb;39(2):1010428317694325
Gusella M et al
2017/01/01
Species: Human PubMed
103 Ruediger CD et al. Influence of ethnic background on left atrial markers of inflammation, endothelial function and tissue remodelling. Indian Pacing Electrophysiol J ;18(1):1-5
Ruediger CD et al
Species: Human PubMed
104 Mailankody S et al. Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis. PLoS ONE 2017;12(7):e0181262
Mailankody S et al
2017/01/01
Species: Human PubMed
105 Lipczyナгka M et al. Collagen turnover biomarkers and systemic right ventricle remodeling in adults with previous atrial switch procedure for transposition of the great arteries. PLoS ONE 2017;12(8):e0180629
Lipczyナгka M et al
2017/01/01
Species: Human PubMed
106 Lorente L et al. Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients. J Crit Care 2019 Jun;51:117-121
Lorente L et al
2019/01/01
PubMed
107 Matulka M et al. Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma. Dis. Markers 2019;2019:3136792
Matulka M et al
2019/01/01
PubMed
108 Zajkowska M et al. Diagnostic power of VEGF, MMP-9 and TIMP-1 in patients with breast cancer. A multivariate statistical analysis with ROC curve. Adv Med Sci 2018 Sep;64(1):1-8
Zajkowska M et al
2018/01/01
PubMed
109 Mulyadi et al. The correlation of age and body mass index with the level of both protease MMP3 and anti-protease TIMP-1 among Indonesian patients with chronic obstructive pulmonary disease: a preliminary findings. BMC Res Notes 2018 Aug;11(1):551
Mulyadi et al
2018/01/01
PubMed
110 Liang ZJ et al. Ginsenoside Rg1 Accelerates Paracrine Activity and Adipogenic Differentiation of Human Breast Adipose-Derived Stem Cells in a Dose-Dependent Manner In Vitro. Cell Transplant 2019 Mar;28(3):286-295
Liang ZJ et al
2019/01/01
PubMed
111 Wu CK et al. Combination of Plasma Biomarkers and Clinical Data for the Detection of Myocardial Fibrosis or Aggravation of Heart Failure Symptoms in Heart Failure with Preserved Ejection Fraction Patients. J Clin Med 2018 Nov;7(11)
Wu CK et al
2018/01/01
PubMed
112 Kunin M et al. Effect of Peritoneal Dialysis on Serum Fibrosis Biomarkers in Patients with Refractory Congestive Heart Failure. Int J Mol Sci 2019 May;20(11)
Kunin M et al
2019/01/01
PubMed
113 Stanciu AE et al. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation. Cytokine 2018 03;103:63-68
Stanciu AE et al
2018/01/01
PubMed
114 Lorente L et al. High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients. BMC Neurol 2019 Jul;19(1):167
Lorente L et al
2019/01/01
PubMed
115 Nguyen EV et al. Identification of Novel Response and Predictive Biomarkers to Hsp90 Inhibitors Through Proteomic Profiling of Patient-derived Prostate Tumor Explants. Mol Cell Proteomics 2018 08;17(8):1470-1486
Nguyen EV et al
2018/01/01
PubMed
116 Kobus A et al. Levels of Selected Matrix Metalloproteinases, Their Inhibitors in Saliva, and Oral Status in Juvenile Idiopathic Arthritis Patients vs. Healthy Controls. Biomed Res Int 2019;2019:7420345
Kobus A et al
2019/01/01
PubMed
117 Singh B et al. Effect of doxycyline in chronic obstructive pulmonary disease - An exploratory study. Pulm Pharmacol Ther 2019 10;58:101831
Singh B et al
2019/01/01
PubMed
118 Zhang DP et al. Basilar Artery Tortuosity Is Associated With White Matter Hyperintensities by TIMP-1. Front Neurosci 2019;13:836
Zhang DP et al
2019/01/01
PubMed
119 Sriphoosanaphan S et al. Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial. PeerJ 2021;9:e10709
Sriphoosanaphan S et al
2021/01/01
Species: Human PubMed
120 Moreno-Ajona D et al. Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: a prospective cohort study. BMC Cardiovasc Disord 2020 02;20(1):93
Moreno-Ajona D et al
2020/01/01
Species: Human PubMed
121 Waszczykowska A et al. Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis-Case Series Report. Int
Waszczykowska A et al
2020/01/01
Species: Human PubMed
122 Moriya K et al. Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis. J Clin Med 2021 Jun;10(11)
Moriya K et al
2021/01/01
Species: Human PubMed
123 Rodr鱈guez-S叩nchez E et al. Variations in Circulating Active MMP-9 Levels During Renal Replacement Therapy. Biomolecules 2020 03;10(4)
Rodr鱈guez-S叩nchez E et al
2020/01/01
Species: Human PubMed
124 Jarecki J et al. Level of Adiponectin, Leptin and Selected Matrix Metalloproteinases in Female Overweight Patients with Primary Gonarthrosis. J Clin Med 2021 Mar;10(6)
Jarecki J et al
2021/01/01
Species: Human PubMed
125 Phillips T et al. Aberrant recruitment of leukocytes defines poor wound healing in patients with recessive dystrophic epidermolysis bullosa. J Dermatol Sci 2020 Dec;100(3):209-216
Phillips T et al
2020/01/01
Species: Human PubMed
126 Stanciu AE et al. Serum melatonin is inversely associated with matrix metalloproteinase-9 in oral squamous cell carcinoma. Oncol Lett 2020 Apr;19(4):3011-3020
Stanciu AE et al
2020/01/01
Species: Human PubMed
  • No.: 1
  • 文献情報:
    Waubant E et al. Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology 1999 Oct;53(7):1397-401
    Waubant E et al
    1999/01/01
  • 備考:
    human serum
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Waubant E et al. IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis. J. Interferon Cytokine Res. 2001 Mar;21(3):181-5
    Waubant E et al
    2001/01/01
  • 備考:
    human serum
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Oelmann E et al. Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells. Blood 2002 Jan;99(1):258-67
    Oelmann E et al
    2002/01/01
  • 備考:
    human plasma and H/R-S cell culture supernate
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Szamatowicz J et al. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis. Hum. Reprod. 2002 Feb;17(2):284-8
    Szamatowicz J et al
    2002/01/01
  • 備考:
    Sample Type: Peritoneal Fluid
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Dam奪s JK et al. Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation 2002 Jul;106(1):36-42
    Dam奪s JK et al
    2002/01/01
  • 備考:
    Sample Type: Cell Supernates,Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Alby C et al. Preanalytical aspects regarding the measurement of metalloproteinase-9 and tissue inhibitor or metalloproteinase-1 in blood. Clin. Chim. Acta 2002 Nov;325(1-2):183-6
    Alby C et al
    2002/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Fireman E et al. Induced sputum-retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases. Clin. Exp. Immunol. 2002 Nov;130(2):331-7
    Fireman E et al
    2002/01/01
  • 備考:
    Sample Type: Saliva
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Cataldo DD et al. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest 2002 Nov;122(5):1553-9
    Cataldo DD et al
    2002/01/01
  • 備考:
    Sample Type: Sputum
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    D"Agostino P et al. Matrix metalloproteinases production in malignant pleural effusions after talc pleurodesis. Clin. Exp. Immunol. 2003 Oct;134(1):138-42
    D"Agostino P et al
    2003/01/01
  • 備考:
    Sample Type: Pleural Effusion,Serum
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Ulrich D et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren"s disease. Plast. Reconstr. Surg. 2003 Oct;112(5):1279-86
    Ulrich D et al
    2003/01/01
  • 備考:
    Species: Human, Application: Serum
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Tziakas DN et al. Anti-inflammatory cytokine profile in acute coronary syndromes: behavior of interleukin-10 in association with serum metalloproteinases and proinflammatory cytokines. Int. J. Cardiol. 2003 Dec;92(2-3):169-75
    Tziakas DN et al
    2003/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Kang MJ et al. Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow. J. Korean Med. Sci. 2003 Dec;18(6):821-7
    Kang MJ et al
    2003/01/01
  • 備考:
    Sample Type: Homogenized Tissue - Protocol Included
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Rhee JS et al. TIMP-1 alters susceptibility to carcinogenesis. Cancer Res. 2004 Feb;64(3):952-61
    Rhee JS et al
    2004/01/01
  • 備考:
    Sample Type: Homogenized Tissue - Protocol Included,Serum
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Jumper C et al. Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment. Respir Med
    Jumper C et al
    2004/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Kuyvenhoven JP et al. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury. Thromb. Haemost. 2004 Mar;91(3):506-13
    Kuyvenhoven JP et al
    2004/01/01
  • 備考:
    Sample Type: Plasma (Citrate)
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Nakano Y et al. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J. Am. Coll. Cardiol. 2004 Mar;43(5):818-25
    Nakano Y et al
    2004/01/01
  • 備考:
    Sample Type: Homogenized Tissue
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Lateef H et al. All-trans-retinoic acid suppresses matrix metalloproteinase activity and increases collagen synthesis in diabetic human skin in organ culture. Am. J. Pathol. 2004 Jul;165(1):167-74
    Lateef H et al
    2004/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Pantsulaia I et al. Heritability of circulating growth factors involved in the angiogenesis in healthy human population. Cytokine 2004 Sep;27(6):152-8
    Pantsulaia I et al
    2004/01/01
  • 備考:
    Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Migita K et al. Suppressive effect of leflunomide metabolite (A77 1726) on metalloproteinase production in IL-1beta stimulated rheumatoid synovial fibroblasts. Clin. Exp. Immunol. 2004 Sep;137(3):612-6
    Migita K et al
    2004/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Domeij H et al. Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 production in human gingival fibroblasts: the role of protein kinase C. J. Periodont. Res. 2004 Oct;39(5):308-14
    Domeij H et al
    2004/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Chellat F et al. Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles. Biomaterials 2005 Mar;26(9):961-70
    Chellat F et al
    2005/01/01
  • 備考:
    Species: Human, Sample type: Cell Supernates
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Maldonado A et al. Pre-exposure to high glucose augments lipopolysaccharide-stimulated matrix metalloproteinase-1 expression by human U937 histiocytes. J. Periodont. Res. 2004 Dec;39(6):415-23
    Maldonado A et al
    2004/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Claveau I et al. Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans. Matrix Biol. 2004 Nov;23(7):477-86
    Claveau I et al
    2004/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Behera AK et al. Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine lyme arthritis. Infect. Immun. 2005 Jan;73(1):126-34
    Behera AK et al
    2005/01/01
  • 備考:
    Sample Type: Cell Supernates,Synovial Fluid
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Sagel SD et al. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis. Pediatr. Pulmonol. 2005 Mar;39(3):224-32
    Sagel SD et al
    2005/01/01
  • 備考:
    human sputum
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    LeMaire SA et al. Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves. J. Surg. Res. 2005 Jan;123(1):40-8
    LeMaire SA et al
    2005/01/01
  • 備考:
    Species: Human, Sample type: Homogenized Tissue
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Studer RK et al. p38 MAPK and COX2 inhibition modulate human chondrocyte response to TGF-beta. J. Orthop. Res. 2005 Mar;23(2):454-61
    Studer RK et al
    2005/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Rouy D et al. Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation. Anal. Biochem. 2005 Mar;338(2):294-8
    Rouy D et al
    2005/01/01
  • 備考:
    Sample Type: Plasma (Citrate)
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Finkelstein A et al. Temporal association between circulating proteolytic, inflammatory and neurohormonal markers in patients with coronary ectasia. Atherosclerosis 2005 Apr;179(2):353-9
    Finkelstein A et al
    2005/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Tayebjee MH et al. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension. Am. J. Hypertens. 2005 Mar;18(3):325-9
    Tayebjee MH et al
    2005/01/01
  • 備考:
    Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Manginas A et al. Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: correlations with serum troponin I. Clin Cardiol 2005 Apr;28(4):182-6
    Manginas A et al
    2005/01/01
  • 備考:
    Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Simpson JL et al. Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am. J. Respir. Crit. Care Med. 2005 Sep;172(5):559-65
    Simpson JL et al
    2005/01/01
  • 備考:
    Sample Type: Sputum
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Ko FW et al. A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion. Chest 2005 Jun;127(6):1919-27
    Ko FW et al
    2005/01/01
  • 備考:
    Sample Type: BALF,Serum
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Domeij H et al. Cell expression of MMP-1 and TIMP-1 in co-cultures of human gingival fibroblasts and monocytes: the involvement of ICAM-1. Biochem. Biophys. Res. Commun. 2005 Dec;338(4):1825-33
    Domeij H et al
    2005/01/01
  • 備考:
    Species: Human, Sample type: Cell Supernates
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Li W et al. Basement membrane dissolution and reassembly by limbal corneal epithelial cells expanded on amniotic membrane. Invest. Ophthalmol. Vis. Sci. 2006 Jun;47(6):2381-9
    Li W et al
    2006/01/01
  • 備考:
    Species: Human, Sample type: Cell Supernates
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Holven KB et al. Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects. Stroke 2006 Jul;37(7):1731-6
    Holven KB et al
    2006/01/01
  • 備考:
    Species: Human, Sample type: Serum
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Demeulemeester D et al. Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in mice does not affect adipogenesis or adipose tissue development. Thromb. Haemost. 2006 Jun;95(6):1019-24
    Demeulemeester D et al
    2006/01/01
  • 備考:
    Species: Human, Sample type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Fluhr H et al. Human chorionic gonadotropin inhibits insulin-like growth factor-binding protein-1 and prolactin in decidualized human endometrial stromal cells. Fertil. Steril. 2006 Jul;86(1):236-8
    Fluhr H et al
    2006/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Fearon U et al. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Arthritis Rheum. 2006 Oct;54(10):3152-62
    Fearon U et al
    2006/01/01
  • 備考:
    Species: Human, Application: Cell Supernates
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Ho FM et al. Opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells. J. Cell. Biochem. 2007 May;101(2):442-50
    Ho FM et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Cell Supernates
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Aznaouridis K et al. Divergent associations of tissue inhibitors of metalloproteinases-1 and -2 with the prothrombotic/fibrinolytic state. Atherosclerosis 2007 Nov;195(1):212-5
    Aznaouridis K et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Plasma
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Andrian E et al. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model. J. Cell. Physiol. 2007 Apr;211(1):56-62
    Andrian E et al
    2007/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Bodet C et al. Actinobacillus actinomycetemcomitans lipopolysaccharide regulates matrix metalloproteinase, tissue inhibitors of matrix metalloproteinase, and plasminogen activator production by human gingival fibroblasts: a potential role in connective ti
    Bodet C et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Cell Supernates
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Zhao Z et al. Borrelia burgdorferi-induced monocyte chemoattractant protein-1 production in vivo and in vitro. Biochem. Biophys. Res. Commun. 2007 Jun;358(2):528-33
    Zhao Z et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Homogenized Tissue, Serum
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Thrailkill KM et al. Matrix metalloproteinase-2 dysregulation in type 1 diabetes. Diabetes Care 2007 Sep;30(9):2321-6
    Thrailkill KM et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Jones JA et al. Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials. J Biomed Mater Res A 2008 Jan;84(1):158-66
    Jones JA et al
    2008/01/01
  • 備考:
    Species: Human, Sample type: Cell Supernates
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Kellouche S et al. Tissue engineering for full-thickness burns: a dermal substitute from bench to bedside. Biochem. Biophys. Res. Commun. 2007 Nov;363(3):472-8
    Kellouche S et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Cell Supernates
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Goleva E et al. Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. J. Allergy Clin. Immunol. 2007 Nov;120(5):1065-72
    Goleva E et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: BALF
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Tuomainen AM et al. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler. Thromb. Vasc. Biol. 2007 Dec;27(12):2722-8
    Tuomainen AM et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Serum
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Li J et al. Suppressive effects of leflunomide on leptin-induced TIMP-1 production involves on hepatic stellate cell proliferation and apoptosis. Eur. J. Pharmacol. 2008 Feb;580(1-2):63-9
    Li J et al
    2008/01/01
  • 備考:
    Species: Human, Application: Cell Supernates
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Huh JW et al. Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis? Chest 2008 May;133(5):1101-6
    Huh JW et al
    2008/01/01
  • 備考:
    Species: Human, Application: BALF
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Kosmala W et al. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function. Int J Obes (Lond) 2008 May;32(5):763-71
    Kosmala W et al
    2008/01/01
  • 備考:
    Species: Human, Application: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Chang DT et al. Lymphocyte/macrophage interactions: biomaterial surface-dependent cytokine, chemokine, and matrix protein production. J Biomed Mater Res A 2008 Dec;87(3):676-87
    Chang DT et al
    2008/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Nicol GR et al. Use of an immunoaffinity-mass spectrometry-based approach for the quantification of protein biomarkers from serum samples of lung cancer patients. Mol. Cell Proteomics 2008 Oct;7(10):1974-82
    Nicol GR et al
    2008/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Glader P et al. Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space. Eur. Respir. J. 2008 Sep;32(3):644-50
    Glader P et al
    2008/01/01
  • 備考:
    Sample Type: BALF
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Bendrik C et al. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo. Cancer Res. 2008 May;68(9):3405-12
    Bendrik C et al
    2008/01/01
  • 備考:
    Species: Human, Application: Homogenized Tissue
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Zdzisiナгka B et al. Matrix metalloproteinases-1 and -2, and tissue inhibitor of metalloproteinase-2 production is abnormal in bone marrow stromal cells of multiple myeloma patients. Leuk. Res. 2008 Nov;32(11):1763-9
    Zdzisiナгka B et al
    2008/01/01
  • 備考:
    Species: Human, Application: Cell Supernates
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Huh JE et al. Protective effects of butanol fraction from Betula Platyphyla var. japonica on cartilage alterations in a rabbit collagenase-induced osteoarthritis. J Ethnopharmacol 2009 Jun;123(3):515-21
    Huh JE et al
    2009/01/01
  • 備考:
    Sample Type: Synovial Fluid
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    McKeown S et al. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur. Respir. J. 2009 Jan;33(1):77-84
    McKeown S et al
    2009/01/01
  • 備考:
    Sample Type: BALF
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Castellano G et al. Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression. Clin. Cancer Res. 2008 Nov;14(22):7470-80
    Castellano G et al
    2008/01/01
  • 備考:
    Sample Type: Plasma (Heparin)
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Kapsoritakis AN et al. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease. BMC Gastroenterol 2008;8:55
    Kapsoritakis AN et al
    2008/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Wang Z et al. Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis? Eur. Respir. J. 2009 Jul;34(1):145-55
    Wang Z et al
    2009/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Glass-Marmor L et al. Immunomodulation by chronobiologically-based glucocorticoids treatment for multiple sclerosis relapses. J. Neuroimmunol. 2009 May;210(1-2):124-7
    Glass-Marmor L et al
    2009/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Gogly B et al. Gingival fibroblast inhibits MMP-7: evaluation in an ex vivo aorta model. J. Mol. Cell. Cardiol. 2009 Aug;47(2):296-303
    Gogly B et al
    2009/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Furuzawa-Carballeda J et al. Effect of polymerized-type I collagen in knee osteoarthritis. I. In vitro study. Eur. J. Clin. Invest. 2009 Jul;39(7):591-7
    Furuzawa-Carballeda J et al
    2009/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    O"Kane CM et al. Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit. Care Med. 2009 Jul;37(7):2242-9
    O"Kane CM et al
    2009/01/01
  • 備考:
    Sample Type: BALF
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Roderfeld M et al. Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation. J. Cyst. Fibros. 2009 Sep;8(5):338-47
    Roderfeld M et al
    2009/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Lorente L et al. Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis. Crit Care 2009;13(5):R158
    Lorente L et al
    2009/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Reikvam H et al. Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation. Eur. J. Haematol. 2010 Mar;84(3):239-51
    Reikvam H et al
    2010/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Pitteri SJ et al. Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. PLoS ONE 2009;4(11):e7916
    Pitteri SJ et al
    2009/01/01
  • 備考:
    Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Teles RM et al. High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions. Infect. Immun. 2010 Mar;78(3):1012-21
    Teles RM et al
    2010/01/01
  • 備考:
    Sample Type: Cell Supernates,Serum
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Guo J et al. A DDX5 S480A polymorphism is associated with increased transcription of fibrogenic genes in hepatic stellate cells. J. Biol. Chem. 2010 Feb;285(8):5428-37
    Guo J et al
    2010/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Tolosana JM et al. Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapy. Eur. J. Heart Fail. 2010 May;12(5):492-8
    Tolosana JM et al
    2010/01/01
  • 備考:
    Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Green JA et al. Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-kappaB- and Activator Protein-1-dependent monocyte networks. J. Immunol. 2010 Jun;184(11):6492-503
    Green JA et al
    2010/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Mroczko B et al. The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients. Int J Colorectal Dis 2010 Oct;25(10):1177-84
    Mroczko B et al
    2010/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Katial RK et al. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases. J. Allergy Clin. Immunol. 2010 Oct;126(4):738-44
    Katial RK et al
    2010/01/01
  • 備考:
    Sample Type: Sputum
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Idriss NK et al. Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor. Thromb. Haemost. 2010 Nov;104(5):1029-37
    Idriss NK et al
    2010/01/01
  • 備考:
    Sample Type: Plasma (Citrate)
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Farlow EC et al. A multi-analyte serum test for the detection of non-small cell lung cancer. Br. J. Cancer 2010 Oct;103(8):1221-8
    Farlow EC et al
    2010/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Hansson J et al. Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study. PLoS ONE 2011;6(1):e16185
    Hansson J et al
    2011/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Symeonidis C et al. Interleukin-6 and the matrix metalloproteinase response in the vitreous during proliferative vitreoretinopathy. Cytokine 2011 May;54(2):212-7
    Symeonidis C et al
    2011/01/01
  • 備考:
    Sample Type: Vitreous Humor
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Meissburger B et al. Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans. Diabetologia 2011 Jun;54(6):1468-79
    Meissburger B et al
    2011/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Kluger HM et al. Plasma markers for identifying patients with metastatic melanoma. Clin. Cancer Res. 2011 Apr;17(8):2417-25
    Kluger HM et al
    2011/01/01
  • 備考:
    Sample Type: Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    J旦nsson S et al. Increased levels of leukocyte-derived MMP-9 in patients with stable angina pectoris. PLoS ONE 2011;6(4):e19340
    J旦nsson S et al
    2011/01/01
  • 備考:
    Sample Type: Cell Supernates,Plasma (Heparin),Serum
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    Geraghty P et al. TLR4 protein contributes to cigarette smoke-induced matrix metalloproteinase-1 (MMP-1) expression in chronic obstructive pulmonary disease. J. Biol. Chem. 2011 Aug;286(34):30211-8
    Geraghty P et al
    2011/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    Kong MY et al. Early elevation of matrix metalloproteinase-8 and -9 in pediatric ARDS is associated with an increased risk of prolonged mechanical ventilation. PLoS ONE 2011;6(8):e22596
    Kong MY et al
    2011/01/01
  • 備考:
    Sample Type: Tracheal Aspirates
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    Kong MY et al. Matrix metalloproteinase activity in pediatric acute lung injury. Int J Med Sci 2009;6(1):9-17
    Kong MY et al
    2009/01/01
  • 備考:
    Sample Type: Endotracheal aspirate
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Pesta M et al. Prognostic significance of TIMP-1 in non-small cell lung cancer. Anticancer Res. 2011 Nov;31(11):4031-8
    Pesta M et al
    2011/01/01
  • 備考:
    Sample Type: Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 88
  • 文献情報:
    Jaedicke KM et al. Validation and quality control of ELISAs for the use with human saliva samples. J. Immunol. Methods 2012 Mar;377(1-2):62-5
    Jaedicke KM et al
    2012/01/01
  • 備考:
    Sample Type: Saliva
  • 参照:
    PubMed
  • No.: 89
  • 文献情報:
    Symeonidis C et al. Interleukin-6 and matrix metalloproteinase expression in the subretinal fluid during proliferative vitreoretinopathy: correlation with extent, duration of RRD and PVR grade. Cytokine 2012 Jul;59(1):184-90
    Symeonidis C et al
    2012/01/01
  • 備考:
    Sample Type: Subretinal fluid
  • 参照:
    PubMed
  • No.: 90
  • 文献情報:
    Ugarte-Gil CA et al. Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis. PLoS ONE 2013;8(4):e61333
    Ugarte-Gil CA et al
    2013/01/01
  • 備考:
    Sample Type: Sputum
  • 参照:
    PubMed
  • No.: 91
  • 文献情報:
    Fontani F et al. Redox regulation of MMP-3/TIMP-1 ratio in intestinal myofibroblasts: effect of N-acetylcysteine and curcumin. Exp. Cell Res. 2014 Apr;323(1):77-86
    Fontani F et al
    2014/01/01
  • 備考:
    Sample Type: Cell culture supernatant
  • 参照:
    PubMed
  • No.: 92
  • 文献情報:
    Lorente L et al. Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury. PLoS ONE 2014;9(4):e94370
    Lorente L et al
    2014/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 93
  • 文献情報:
    Uezumi A et al. Identification and characterization of PDGFRα+ mesenchymal progenitors in human skeletal muscle. Cell Death Dis 2014;5:e1186
    Uezumi A et al
    2014/01/01
  • 備考:
    Sample Type: Cell Culture Supernates
  • 参照:
    PubMed
  • No.: 94
  • 文献情報:
    Zhao R et al. Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model. J Transl Med 2014;12(1):330
    Zhao R et al
    2014/01/01
  • 備考:
    Sample Type: Serum,Synovial Fluid
  • 参照:
    PubMed
  • No.: 95
  • 文献情報:
    Kmiecik AM et al. Metallothionein-3 Increases Triple-Negative Breast Cancer Cell Invasiveness via Induction of Metalloproteinase Expression. PLoS ONE 2015;10(5):e0124865
    Kmiecik AM et al
    2015/01/01
  • 備考:
    Sample Type: Cell Culture Supernates
  • 参照:
    PubMed
  • No.: 96
  • 文献情報:
    Nalluri S et al. TIMP-1 Inhibits Apoptosis in Lung Adenocarcinoma Cells via Interaction with Bcl-2. PLoS ONE 2015;10(9):e0137673
    Nalluri S et al
    2015/01/01
  • 備考:
    Sample Type: Cell Culture Supernates,Cell Lysates
  • 参照:
    PubMed
  • No.: 97
  • 文献情報:
    Thevenard J et al. Low-density lipoprotein receptor-related protein-1 mediates endocytic clearance of tissue inhibitor of metalloproteinases-1 and promotes its cytokine-like activities. PLoS ONE 2014;9(7):e103839
    Thevenard J et al
    2014/01/01
  • 備考:
    Sample Type: Cell Culture Supernates
  • 参照:
    PubMed
  • No.: 98
  • 文献情報:
    Yang J et al. Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nat Commun 2016 Dec;7:13710
    Yang J et al
    2016/01/01
  • 備考:
    Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 99
  • 文献情報:
    Mieczkowska J et al. Relationship between Serum Levels of Metalloproteinase-8 and Tissue Inhibitor of Metalloproteinases-1 and Exercise Test Results in Postmenopausal Women. Dis. Markers 2016;2016:7169531
    Mieczkowska J et al
    2016/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 100
  • 文献情報:
    Ni単o ME et al. TIMP1 and MMP9 are predictors of mortality in septic patients in the emergency department and intensive care unit unlike MMP9/TIMP1 ratio: Multivariate model. PLoS ONE 2017;12(2):e0171191
    Ni単o ME et al
    2017/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 101
  • 文献情報:
    Schmalz G et al. MMP-8 and TIMP-1 are associated to periodontal inflammation in patients with rheumatoid arthritis under methotrexate immunosuppression - First results of a cross-sectional study. J Microbiol Immunol Infect 2017 Sep;
    Schmalz G et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 102
  • 文献情報:
    Gusella M et al. Plasma matrix metalloprotease 9 correlates with blood lymphocytosis, leukemic cell invasiveness, and prognosis in B-cell chronic lymphocytic leukemia. Tumour Biol. 2017 Feb;39(2):1010428317694325
    Gusella M et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 103
  • 文献情報:
    Ruediger CD et al. Influence of ethnic background on left atrial markers of inflammation, endothelial function and tissue remodelling. Indian Pacing Electrophysiol J ;18(1):1-5
    Ruediger CD et al
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 104
  • 文献情報:
    Mailankody S et al. Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis. PLoS ONE 2017;12(7):e0181262
    Mailankody S et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 105
  • 文献情報:
    Lipczyナгka M et al. Collagen turnover biomarkers and systemic right ventricle remodeling in adults with previous atrial switch procedure for transposition of the great arteries. PLoS ONE 2017;12(8):e0180629
    Lipczyナгka M et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 106
  • 文献情報:
    Lorente L et al. Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients. J Crit Care 2019 Jun;51:117-121
    Lorente L et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 107
  • 文献情報:
    Matulka M et al. Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma. Dis. Markers 2019;2019:3136792
    Matulka M et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 108
  • 文献情報:
    Zajkowska M et al. Diagnostic power of VEGF, MMP-9 and TIMP-1 in patients with breast cancer. A multivariate statistical analysis with ROC curve. Adv Med Sci 2018 Sep;64(1):1-8
    Zajkowska M et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 109
  • 文献情報:
    Mulyadi et al. The correlation of age and body mass index with the level of both protease MMP3 and anti-protease TIMP-1 among Indonesian patients with chronic obstructive pulmonary disease: a preliminary findings. BMC Res Notes 2018 Aug;11(1):551
    Mulyadi et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 110
  • 文献情報:
    Liang ZJ et al. Ginsenoside Rg1 Accelerates Paracrine Activity and Adipogenic Differentiation of Human Breast Adipose-Derived Stem Cells in a Dose-Dependent Manner In Vitro. Cell Transplant 2019 Mar;28(3):286-295
    Liang ZJ et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 111
  • 文献情報:
    Wu CK et al. Combination of Plasma Biomarkers and Clinical Data for the Detection of Myocardial Fibrosis or Aggravation of Heart Failure Symptoms in Heart Failure with Preserved Ejection Fraction Patients. J Clin Med 2018 Nov;7(11)
    Wu CK et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 112
  • 文献情報:
    Kunin M et al. Effect of Peritoneal Dialysis on Serum Fibrosis Biomarkers in Patients with Refractory Congestive Heart Failure. Int J Mol Sci 2019 May;20(11)
    Kunin M et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 113
  • 文献情報:
    Stanciu AE et al. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation. Cytokine 2018 03;103:63-68
    Stanciu AE et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 114
  • 文献情報:
    Lorente L et al. High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients. BMC Neurol 2019 Jul;19(1):167
    Lorente L et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 115
  • 文献情報:
    Nguyen EV et al. Identification of Novel Response and Predictive Biomarkers to Hsp90 Inhibitors Through Proteomic Profiling of Patient-derived Prostate Tumor Explants. Mol Cell Proteomics 2018 08;17(8):1470-1486
    Nguyen EV et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 116
  • 文献情報:
    Kobus A et al. Levels of Selected Matrix Metalloproteinases, Their Inhibitors in Saliva, and Oral Status in Juvenile Idiopathic Arthritis Patients vs. Healthy Controls. Biomed Res Int 2019;2019:7420345
    Kobus A et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 117
  • 文献情報:
    Singh B et al. Effect of doxycyline in chronic obstructive pulmonary disease - An exploratory study. Pulm Pharmacol Ther 2019 10;58:101831
    Singh B et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 118
  • 文献情報:
    Zhang DP et al. Basilar Artery Tortuosity Is Associated With White Matter Hyperintensities by TIMP-1. Front Neurosci 2019;13:836
    Zhang DP et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 119
  • 文献情報:
    Sriphoosanaphan S et al. Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial. PeerJ 2021;9:e10709
    Sriphoosanaphan S et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 120
  • 文献情報:
    Moreno-Ajona D et al. Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: a prospective cohort study. BMC Cardiovasc Disord 2020 02;20(1):93
    Moreno-Ajona D et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 121
  • 文献情報:
    Waszczykowska A et al. Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis-Case Series Report. Int
    Waszczykowska A et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 122
  • 文献情報:
    Moriya K et al. Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis. J Clin Med 2021 Jun;10(11)
    Moriya K et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 123
  • 文献情報:
    Rodr鱈guez-S叩nchez E et al. Variations in Circulating Active MMP-9 Levels During Renal Replacement Therapy. Biomolecules 2020 03;10(4)
    Rodr鱈guez-S叩nchez E et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 124
  • 文献情報:
    Jarecki J et al. Level of Adiponectin, Leptin and Selected Matrix Metalloproteinases in Female Overweight Patients with Primary Gonarthrosis. J Clin Med 2021 Mar;10(6)
    Jarecki J et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 125
  • 文献情報:
    Phillips T et al. Aberrant recruitment of leukocytes defines poor wound healing in patients with recessive dystrophic epidermolysis bullosa. J Dermatol Sci 2020 Dec;100(3):209-216
    Phillips T et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 126
  • 文献情報:
    Stanciu AE et al. Serum melatonin is inversely associated with matrix metalloproteinase-9 in oral squamous cell carcinoma. Oncol Lett 2020 Apr;19(4):3011-3020
    Stanciu AE et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed